Tanrikulu, F. P. Et Al. 2022. The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension. CUKUROVA MEDICAL JOURNAL , vol.47, no.3 , 1015-1023.

Tanrikulu, F. P., BABAOĞLU, M. Ö., ÇAKIR, B., BOZKURT, A., & Guven, G. S., (2022). The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension. CUKUROVA MEDICAL JOURNAL , vol.47, no.3, 1015-1023.

Tanrikulu, Funda Et Al. "The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension," CUKUROVA MEDICAL JOURNAL , vol.47, no.3, 1015-1023, 2022

Tanrikulu, Funda P. Et Al. "The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension." CUKUROVA MEDICAL JOURNAL , vol.47, no.3, pp.1015-1023, 2022

Tanrikulu, F. P. Et Al. (2022) . "The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension." CUKUROVA MEDICAL JOURNAL , vol.47, no.3, pp.1015-1023.

@article{article, author={Funda Pepedil Tanrikulu Et Al. }, title={The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension}, journal={CUKUROVA MEDICAL JOURNAL}, year=2022, pages={1015-1023} }